Table 1.
Demographic and clinical data of the patient population at baseline.
| Gender (M/F) | 10 M |
|---|---|
| Age (years) | 57.0 ± 10.2 |
| Dry body weight (kg) | 74.7 [69.7;89.1] |
| Dialysis vintage (months) | 23.1 [12.5;40.9] |
| Renal disease | Autosomal dominant polycystic kidney disease (n = 3); IgA nephropathy (n = 2); diabetic nephropathy (n = 1); reflux nephropathy (n = 1); focal segmental glomerulosclerosis (n = 1); membranous glomerulonephritis (n = 1); Alport (n = 1) |
| Regular anticoagulation dose | Enoxaparin 40 mg (n = 5); Tinzaparin 3500 (n = 4); Enoxaparin 60 mg (n = 1) |
| Platelet inhibitors | Acetylsalicylic acid 80 mg (n = 7) |
| Hb (g/dL) | 12.0 ± 0.7 |
| Platelets count (103/µL) | 224 ± 56 |
| aPTT (s) | 34.6 ± 2.6 |
| INR (-) | 1.0 ± 0.1 |
| CRP (mg/L) | 5.2 [2.3;7.0] |
Hb: hemoglobin; aPTT: activated partial thromboplastin time; INR: international normalized ratio; CRP: C-reactive protein.